RESPONSE FORM_ FY27 Fracture Detection SSN.docx
DOCX document 29 KB Posted
- Solicitation number
- BARDA-FY27-10192026
About this file
This is an Offeror Technical Response Form for a Sources Sought Notice (SSN) issued by the Center for Biomedical Advanced Research and Development Authority (BARDA) under solicitation BARDA-FY27-10192026. The form is a standardized market research template designed to collect information about technologies capable of detecting and characterizing clinically significant fractures using automated ultrasound-based Super Intelligence (SI)-enabled systems. This is not a solicitation or commitment to award a contract, but rather a pre-solicitation effort to assess commercially available and near-commercial technologies for potential future acquisition.
The response form requires offerors to provide comprehensive technical and capability information organized across six primary sections: (1) Display and Diagnostic Capability, including detection of long-bone, wrist, and ankle fractures, AI-assisted interpretation, sensitivity/specificity data, 3D reconstruction, and performance comparisons against X-ray and CT imaging; (2) Device Design and Portability, covering form factor, durability for field/disaster response, weight, dimensions, battery specifications, processing capability, connectivity, and offline operation; (3) Use-Case Flexibility and Workflow, addressing operation in austere and hospital environments, operator qualifications, training duration, mass-casualty triage support, examination time, and workflow compatibility; (4) Clinical and Regulatory Maturity, including current FDA status, regulatory feedback, clinical evidence, peer-reviewed publications, and development roadmaps; (5) Scalability, Manufacturing, and Supply Chain, detailing U.S. manufacturing locations, production capacity, quality certifications, and supply-chain risks; and (6) Indicated Population and Use Cases, documenting performance across adult/pediatric populations, blast injuries, blunt trauma, structural collapse, and other trauma mechanisms. Offerors must distinguish demonstrated capabilities from those in development or proposed, cite supporting evidence, and clearly identify proprietary or restricted information. BARDA intends to use responses to inform planning for potential device purchases or leases supported by vendor-managed inventory (VMI) arrangements to support triage and treatment in emergency departments, urgent care centers, and field settings.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Sources Sought Number BARDA FY27 10192026.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
SOURCES SOUGHT NOTICE
Automated Ultrasound-Based AI Enabled Fracture Detection Offeror Technical Response Form Purpose. This form is intended to collect standardized market research information regarding technologies capable of detecting and characterizing clinically significant fractures using ultrasound. It is not a solicitation, request for proposal, or commitment to acquire any technology.
Instructions to Offerors Complete all applicable fields. If a capability is not available, enter “Not Available” or “Not Applicable” rather than leaving the field blank.
Use space provided to summarize requested information. Attach additional, brief summaries when space provided is not sufficient.
Identify whether each capability is demonstrated, under development, or proposed. Clearly distinguish measured performance from anticipated performance.
Cite supporting evidence. Attach supporting publications, test reports, regulatory materials, product literature, or other documentation as appropriate.
For diagnostic performance, provide the study population, comparator, sample size, fracture distribution, operator characteristics, and statistical confidence intervals whenever available.
Where information is proprietary or controlled, identify the restriction and provide a non-proprietary summary sufficient for market research.
Offeror and Product Identification
| Field |
| Offeror Response |
Company / Organization Name
Commercial Product / Technology Name
Product Model / Version
Company Website
Primary Point of Contact / Title
Email / Telephone
DUNS / UEI (if applicable)
Place(s) of Manufacture
| U.S. Manufacturing Capability |
| ☐ Yes ☐ No ☐ Planned ☐ Other: __________ |
| Current Product Status |
| ☐ Commercial ☐ Prototype ☐ Development ☐ Research system ☐ Other: ______ |
Executive Technology Summary Provide a concise (≤500 words) description of the technology, intended use, principal differentiators, current maturity, and anticipated use in trauma/mass-casualty settings.
1. DISPLAY AND Diagnostic Capability
| Capability / Requirement |
| Status |
| Detects long-bone fractures |
| ☐ Demonstrated ☐ Development ☐ Planned ☐ N/A |
| Detects wrist fractures |
| ☐ Demonstrated ☐ Development ☐ Planned ☐ N/A |
| Detects ankle fractures |
| ☐ Demonstrated ☐ Development ☐ Planned ☐ N/A |
| Other clinically significant fracture locations (specify) |
| ☐ Demonstrated ☐ Development ☐ Planned ☐ N/A |
| AI-assisted interpretation |
| ☐ On device ☐ Cloud ☐ Both ☐ None |
| Sensitivity |
| ☐ Measured ☐ Estimated ☐ Not available |
| Specificity |
| ☐ Measured ☐ Estimated ☐ Not available |
| PPV / NPV, if available |
| ☐ Measured ☐ Estimated ☐ N/A |
| Distinguishes fracture type/severity |
| ☐ Demonstrated ☐ Development ☐ Planned ☐ N/A |
| 3D bone/fracture reconstruction |
| ☐ Demonstrated ☐ Development ☐ Planned ☐ N/A |
| 3D rendering for clinician review |
| ☐ Demonstrated ☐ Development ☐ Planned ☐ N/A |
| Comparison against X-ray |
| ☐ Yes ☐ No ☐ Planned |
| Comparison against CT |
| ☐ Yes ☐ No ☐ Planned |
| Other comparator / gold standard |
| ☐ Yes ☐ No ☐ Planned |
Summarize diagnostic performance study details: study design, population, number of subjects/scans, fracture types/sites, operator training, comparator, sensitivity/specificity, confidence intervals, and limitations.
2. Device Design and Portability
| Parameter |
| Offeror Response |
| Standalone, point-of-care form factor with integrated AI-processing |
| ☐ Yes ☐ No ☐ Planned — Explain: |
| Durable/ruggedized for field and disaster-response conditions |
| ☐ Yes ☐ No ☐ Planned — Explain: |
| Self-contained with all necessary supplies in a single, portable unit |
| ☐ Yes ☐ No ☐ Planned — Explain: |
| EHR / hospital system interoperability |
| ☐ Yes ☐ No ☐ Planned — Explain: |
Total weight (device + required accessories)
Dimensions
Battery type / capacity / operating time
Recharge time / charging method
External power requirements / voltage
Integrated processing capability
Display / output characteristics
Data storage capacity
Data export formats
Connectivity requirements
Offline operation capability
Ruggedization / protective enclosure
3. Use-Case Flexibility and Workflow
| Question |
| Offeror Response |
| Can system operate in austere/field environments? |
| ☐ Yes ☐ No ☐ Planned — Explain: |
| Can system operate in hospital/clinical environments? |
| ☐ Yes ☐ No ☐ Planned — Explain: |
| Can non-specialist operators acquire images? |
| ☐ Yes ☐ No ☐ With training — Describe: |
| Can non-specialist operators interpret results? |
| ☐ Yes ☐ No ☐ AI-assisted — Describe: |
Typical training duration to independent operation?
| Can system operate without reliable network connectivity? |
| ☐ Yes ☐ No ☐ Degraded mode — Describe: |
| Supports mass-casualty triage workflow? |
| ☐ Yes ☐ No ☐ Planned — Describe: |
Typical examination time per anatomical site?
Minimum number of operators required?
| Compatibility with existing trauma workflows? |
| ☐ Yes ☐ No ☐ Planned — Describe: |
Describe the intended point-of-care workflow from patient selection through image acquisition, AI analysis, diagnostic output, documentation, and disposition.
4. Clinical and Regulatory Maturity
| Item |
| Offeror Response |
| Current FDA status |
| ☐ In development ☐ Pre-Submission ☐ Breakthrough ☐ 510(k) cleared |
☐ De Novo ☐ Other:
| Formal FDA feedback received |
| ☐ Yes ☐ No ☐ Planned — Describe below |
FDA submission number(s), if applicable
Regulatory interactions to date
Clinical evidence available
Peer-reviewed publications
| Related work with other Federal Agencies |
| ☐ Yes: Agency(ies):___________________________________________ ☐ No |
| Related Federal work summaries |
| Attach brief summaries as necessary |
Provide a summary of clinical testing completed to date (algorithm training/validation, human factors, MRMC) with performance results. Summarize the development roadmap identifying major technical, clinical, regulatory, manufacturing, and field-validation milestones. Include any major risks and mitigations. Include dates and brief summaries of recent, formal FDA feedback received to support intended regulatory pathway.
5. Scalability, Manufacturing, AND SUPPLY CHAIN
| Topic |
| Offeror Response |
U.S. manufacturing location(s)
Current annual production capacity
Time to scale production
Manufacturing process maturity
Quality system / certification
Critical components / suppliers
Single-source dependencies
Alternative component sources
Supply-chain risks / mitigations
Inventory / warehousing strategy
6. Indicated Population and Use Cases
| Use Case / Population |
| Current Evidence (links) |
Adults
Pediatrics
Blast injury
Blunt trauma
Structural collapse / crush injury
Mass-casualty incidents
Long-bone fractures
Wrist fractures
Ankle fractures
Other anatomical sites
Other trauma mechanisms / populations
Describe known performance limitations, contraindications, anatomical limitations, body-habitus considerations, operator limitations, or other factors affecting use.
Offeror Certification and Contact
| Certification Item |
| Offeror Response |
Information provided by
Title / Organization
Date
Signature (if required)
Telephone
Point-of-contact for technical questions
Point-of-contact for contracting/business questions
Submission Note: Offerors should clearly identify proprietary, confidential, export-controlled, or otherwise restricted information. Responses should distinguish currently demonstrated capabilities from planned or conceptual capabilities. Supporting evidence should be traceable to the claims made in this form.
Automated Ultrasound-Based AI Enabled Fracture Detection — Sources Sought Offeror Response Form
File details come from the government source that posted it. Updated .